poisar

Stocks · News reference

Cboe Global Markets Q2 Adj. EPS $3.56 Beats $3.48 Estimate, Sales $731.600M Beat $712.157M Estimate

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CBOE
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Erin Kennedy

    CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?

    CME Group and Morningstar are compared as financial infrastructure plays. CME dominates derivatives trading with an impressive 62% net margin and $6.5B revenue, but trades at a premium valuation (forward P/E 22.5). Morningstar offers investment research with lower margins (15.3%) but more attractive valuation (forward P/E 15.5). The author leans toward CME despite valuation concerns due to its superior profitability and dividend, though both stocks have underperformed the S&P 500 over longer periods.

    CMEMORNICECBOEMSCI
  2. Na

    NDAQ Boosts AI and Data-Driven Investment Technology With Dasseti

    Nasdaq has completed its acquisition of Dasseti, an AI-powered due diligence and monitoring platform, expanding its institutional investment-technology capabilities. The deal integrates Dasseti into eVestment and provides access to an ecosystem of 17,000 asset managers representing $34 trillion in AUM, supporting Nasdaq's shift toward higher-value data, analytics, and workflow technology.

    NDAQCBOEICE